Proposed Data Collections Submitted for Public Comment and Recommendations, 4126-4127 [05-1589]
Download as PDF
<![CDATA[
4126
Federal Register / Vol. 70, No. 18 / Friday, January 28, 2005 / Notices
II. 15 NOTICES OF COMMENCEMENT FROM: 12/01/04 TO 12/14/04—Continued
Case No.
Commencement
Notice End Date
Received Date
P–04–0519
11/30/04
11/24/04
P–04–0611
P–04–0626
12/07/04
12/08/04
11/03/04
11/09/04
P–04–0659
12/14/04
11/16/04
P–04–0683
P–04–0710
P–04–0752
P–04–0793
P–04–0815
P–04–0891
P–93–1704
12/06/04
12/06/04
11/30/04
12/06/04
12/06/04
12/01/04
12/13/04
11/23/04
11/15/04
11/12/04
11/20/04
11/16/04
11/02/04
11/29/04
List of Subjects
Environmental protection, Chemicals,
Premanufacturer notices.
Dated: January 13, 2005.
Vicki A. Simons,
Acting Director, Information Management
Division, Office of Pollution Prevention and
Toxics.
[FR Doc. 05–1637 Filed 1–27–05; 8:45 am]
BILLING CODE 6560–50–S
EXPORT–IMPORT BANK OF THE
UNITED STATES
Sunshine Act Meeting
Notice of a partially open
meeting of the Board of Directors of the
Export-Import Bank of the United
States.
ACTION:
Thursday, February 3,
2005 at 9:30 a.m. The meeting will be
held at Ex-Im Bank in Room 1143, 811
Vermont Avenue, NW., Washington, DC
20571.
TIME AND PLACE:
Ex-Im Bank SubSaharan Africa Advisory Committee for
2005.
OPEN AGENDA ITEM:
The meeting will
be open to public participation for Item
No. 1 only.
PUBLIC PARTICIPATION:
For further
information, contact: Office of the
Secretary, 811 Vermont Avenue, NW.,
Washington, DC 20571 (Tel. No. (202)
565–3957).
FURTHER INFORMATION:
James K. Hess,
Senior Vice President and Chief Financial
Officer.
[FR Doc. 05–1727 Filed 1–26–05; 12:39 pm]
BILLING CODE 6690–01–M
VerDate jul<14>2003
15:43 Jan 27, 2005
Jkt 205001
Chemical
(G) Substituted benzenesulfonic acid substituted pyrazol azo phenyl amino
triazin amino substituted phenyl compound
(S) (1r,4s)-4-methoxy-2,2,7,7-tetramethyltricyclo[6.2.1.01,6]undec-5-ene
(G) Substituted phenol, polymer with polyalkylene polyether polyol and
epichlorohydrin
(G) N-sulfoalkyl-aminocarbonylalkenyl, polymer modified with n,n-dialkylaminocarbonylalkenyl, calcium salt
(G) Substituted pyridinecarbonitrile pigment
(G) Alkyl methacrylate copolymer
(G) Organomodified siloxane and silicone
(G) Essential oil
(G) Styrene acrylic copolymer
(G) Dynacoll 7250, dynacoll 7140
(G) Polyester polyol isocyanate polymer reaction products
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Committee on Vital and Health
Statistics: Meeting
Pursuant to the Federal Advisory
Committee Act, the Department of
Health and Human Services (HHS)
announces the following advisory
committee meeting.
Name: National Committee on Vital and
Health Statistics (NCVHS), Subcommittee on
Standards and Security (SSS).
Time and Date: February 1st, 2005 9 a.m.–
5 p.m., February 2nd, 2005 9 a.m.–1 p.m.
Place: Hubert H. Humphrey Building, 200
Independence Avenue, SW., Room 505A,
Washington, DC 20201.
Status: Open.
Purpose: The Subcommittee will continue
to focus on potential e-prescribing standards,
including a discussion on the use of RxNorm
in the e-prescribing context and an update
from the industry on the progress of related
workgroups (e.g., codified SIG). The
development of a draft recommendation
letter to the HHS Secretary will be discussed.
Contact Person For More Information:
Substantive program information as well as
summaries of meetings and a roster of
Committee members may be obtained from
Maria Friedman, Health Insurance Specialist,
Security and Standards Group, Centers for
Medicare and Medicaid Services, MS: C5–
24–04, 7500 Security Boulevard, Baltimore,
MD 21244–1850, telephone: 410–786–6333
or Marjorie S. Greenberg, Executive
Secretary, NCVHS, National Center for
Health Statistics, Centers for Disease Control
and Prevention, Room 1100, Presidential
Building, 3311 Toledo Road, Hyattsville,
Maryland 20782, telephone: (301) 458–4245.
Information also is available on the NCVHS
home page of the HHS Web site: https://
www.ncvhs.hhs.gov/ where an agenda for the
meeting will be posted when available.
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment Opportunity on
(301) 458–4EEO (4336) as soon as possible.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Dated: January 14, 2005.
James Scanlon,
Acting Deputy Assistant Secretary for Science
and Data Policy, Office of the Assistant
Secretary for Planning and Evaluation.
[FR Doc. 05–1619 Filed 1–27–05; 8:45 am]
BILLING CODE 4151–05–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–0263]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call (404) 371–5976 or
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
E:\FR\FM\28JAN1.SGM
28JAN1
4127
Federal Register / Vol. 70, No. 18 / Friday, January 28, 2005 / Notices
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Requirement for a Special Permit to
Import Cynomolgus, African Green, or
Rhesus Monkeys into the United States
(0920–0263)—Revision—National
Center for Infectious Diseases (NCID),
Centers for Disease Control and
Prevention (CDC).
A registered importer must request a
special permit to import Cynomolgus,
African Green, or Rhesus Monkeys. To
receive a special permit to import
nonhuman primates the importer must
submit to the Director of CDC, a written
plan which specifies the steps that will
be taken to prevent exposure of persons
and animals during the entire
importation and quarantine process for
the arriving nonhuman primates.
Under the special permit
arrangement, registered importers must
submit a plan to CDC for the
importation and quarantine if they wish
to import the specific monkeys covered.
The plan must address disease
prevention procedures to be carried out
in every step of the chain of custody of
such monkeys, from embarkation in the
country of origin to release from
quarantine. Information such as species,
origin and intended use for monkeys,
transit information, isolation and
quarantine procedures, and procedures
for testing of quarantined animals is
necessary for CDC to make public health
decisions. This information enables
CDC to evaluate compliance with the
standards and to determine whether the
measures being taken to prevent
exposure of persons and animals during
importation are adequate. Once CDC is
assured, through the monitoring of
Number of
responses
per
respondent
Number of
respondents
Respondents
shipments (normally no more than 2),
that the provisions of a special permit
plan are being followed by a new permit
holder and that the use of adequate
disease control practices is being
demonstrated, the special permit is
extended to cover the receipt of
additional shipments under the same
plan for a period of 180 days, and may
be renewed upon request. This
eliminates the burden on importers to
repeatedly report identical information,
requiring only that specific shipment
itineraries and information on changes
to the plan which require approval be
submitted.
Respondents are commercial or notfor-profit importers of nonhuman
primates. The burden represents full
submission of information and
itinerary/change information
respectively. There are no costs to
respondents except for their time to
complete the requisition process.
Average
burden per
response
(in hours)
Total burden
hours
Business (limited permit) ...............................................................................
Businesses (extended permit) .......................................................................
Organizations (limited permit) ........................................................................
Organizations (extended permit) ...................................................................
5
1
3
12
2
3
2
2
30/60
10/60
30/60
10/60
5
.5
3
4
Total ........................................................................................................
........................
........................
........................
12.5
Dated: January 21, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of
the Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. 05–1589 Filed 1–27–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–50 and CMS–
10054]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
AGENCY:
VerDate jul<14>2003
15:43 Jan 27, 2005
Jkt 205001
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medical Records
Review under Inpatient PPS and
Supporting Regulations in 42 CFR,
Sections 412.40–412.52; Form No:
CMS–R–50 (OMB# 0938–0359); Use:
The Quality Improvement Organizations
(QIOs) are authorized to conduct
medical review activities under the
Prospective Payment System (PPS). In
order to conduct these review activities,
CMS depends upon hospitals to make
available specific records regarding care
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
provided to Medicare beneficiaries. The
Clinical Data Abstraction Centers
(CDACs) obtain copies of medical
records from which they abstract data to
analyze patterns of care and outcomes
for heart failure/myocardial infarction,
pneumonia, diabetes and surgical
infection; Frequency: When records are
reviewed; Affected Public: Business or
other for-profit, Not-for-profit
institutions, Federal Government, and
State, Local or Tribal Government;
Number of Respondents: 6,100; Total
Annual Responses: 397,500; Total
Annual Hours: 11,925.
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Recognition of
Payment for New Technology Services
for Ambulatory Payment Classifications
(APCs) Under the Outpatient
Prospective Payment System and
Supporting Regulations in 42 CFR,
Sections 413.65 and 419.42; Form
Number: CMS–10054 (OMB# 0938–
0860); Use: Information is necessary to
determine eligibility of medical devices
for establishment of additional device
categories for payment under
transitional pass-through payment
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 70, Number 18 (Friday, January 28, 2005)]
[Notices]
[Pages 4126-4127]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-1589]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05-0263]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call (404) 371-5976
or send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information
[[Page 4127]]
on respondents, including through the use of automated collection
techniques or other forms of information technology. Written comments
should be received within 60 days of this notice.
Proposed Project
Requirement for a Special Permit to Import Cynomolgus, African
Green, or Rhesus Monkeys into the United States (0920-0263)--Revision--
National Center for Infectious Diseases (NCID), Centers for Disease
Control and Prevention (CDC).
A registered importer must request a special permit to import
Cynomolgus, African Green, or Rhesus Monkeys. To receive a special
permit to import nonhuman primates the importer must submit to the
Director of CDC, a written plan which specifies the steps that will be
taken to prevent exposure of persons and animals during the entire
importation and quarantine process for the arriving nonhuman primates.
Under the special permit arrangement, registered importers must
submit a plan to CDC for the importation and quarantine if they wish to
import the specific monkeys covered. The plan must address disease
prevention procedures to be carried out in every step of the chain of
custody of such monkeys, from embarkation in the country of origin to
release from quarantine. Information such as species, origin and
intended use for monkeys, transit information, isolation and quarantine
procedures, and procedures for testing of quarantined animals is
necessary for CDC to make public health decisions. This information
enables CDC to evaluate compliance with the standards and to determine
whether the measures being taken to prevent exposure of persons and
animals during importation are adequate. Once CDC is assured, through
the monitoring of shipments (normally no more than 2), that the
provisions of a special permit plan are being followed by a new permit
holder and that the use of adequate disease control practices is being
demonstrated, the special permit is extended to cover the receipt of
additional shipments under the same plan for a period of 180 days, and
may be renewed upon request. This eliminates the burden on importers to
repeatedly report identical information, requiring only that specific
shipment itineraries and information on changes to the plan which
require approval be submitted.
Respondents are commercial or not-for-profit importers of nonhuman
primates. The burden represents full submission of information and
itinerary/change information respectively. There are no costs to
respondents except for their time to complete the requisition process.
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Respondents respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Business (limited permit)...................... 5 2 30/60 5
Businesses (extended permit)................... 1 3 10/60 .5
Organizations (limited permit)................. 3 2 30/60 3
Organizations (extended permit)................ 12 2 10/60 4
-----------------
Total...................................... .............. .............. .............. 12.5
----------------------------------------------------------------------------------------------------------------
Dated: January 21, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of the Chief Science Officer,
Centers for Disease Control and Prevention.
[FR Doc. 05-1589 Filed 1-27-05; 8:45 am]
BILLING CODE 4163-18-P
